
About Nutrition 21
Nutrition 21 is pioneering an effort to use patented technology, pharmaceutical research and strategic marketing and distribution partnerships to build its position in therapeutic markets. The Company is targeting cardiovascular health, diabetes, arthritis, obesity, mood disorders, immune function and anti-aging through its Chromax, Diachrome, Iceland Health, Perfect Skin, and Selenomax brands. Nutrition 21 relies on large-scale double-blind placebo-controlled clinical trials as a key element of its marketing strategy. The company's objective is to translate its scientific findings into trusted brands recognized for their measurable contribution to improving public health and reducing cost of care. The Company earns the trust of consumers with endorsements by healthcare professionals and by getting our products adopted as a standard treatment recommended by doctors and health care professionals. Different from most biotechnology or pharmaceutical companies, the Company is focused on developing products that are marketed under the Dietary Supplement Health and Education Act (DSHEA) regulatory pathway. The Food and Drug Administration's (FDA) regulations for the supplement category enable companies to bring products to market in less time and with less cost than is required for FDA drug approval. Armed with clinical evidence that promises to reveal remarkable, clinically measurable effects of its products in therapeutic approaches to epidemic diseases like heart disease, diabetes, arthritis, obesity, depression and immune system dysfunction, Nutrition 21 enjoys the following unique competitive advantages:
|



